Back to Agenda
Session 2: Pharmacovigilance Updates & Collaboration Efforts From Around the Globe
Session Chair(s)
Shahinaz Badr, PHARMD
Founder & Managing Director, Vigilance Gate FZ,LLC, United Arab Emirates
Willemijn van der Spuij, MSC
Executive Director Europe | International - Patient Safety, Bristol Myers Squibb, Switzerland
This truly global session aims to provide insights into the latest developments in Pharmacovigilance. The session will take you on a journey around the world, starting with an exploration of PV requirements and experiences in Kazakhstan. We will then move on to the PV environment and collaborative efforts in Brazil. Next, we will focus on important PV developments in the Asia Pacific region. The session will highlight key aspects that impact the role of the QPPV. You will have the opportunity to engage directly with experts from the industry and regulatory agencies during the panel discussion.
Speaker(s)
Willemijn van der Spuij, MSC
Executive Director Europe | International - Patient Safety, Bristol Myers Squibb, Switzerland
Kazakhstan - Industry Experience of the Regulatory Framework and Interpretation to Inspection Experiences
Representative Invited
, Switzerland
Asia PAC Region – Increasing Role of NQPs Over Time
Maha Mohamed Ahmed
Acting Director of the general department of pharmacovigilance, Egyptian Drug Authority (EDA), Egypt
Local QPPV Role in Egypt
LatAmScience LLC
, United States
Diana Gonzalez, MD, MBA
Colombia PSL & PV Policy Lead Latam , Roche, Colombia
Have an account?